United States HR 679: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Status: Introduced in House (as of 2025-01-23)

State: United States · Session: 119 · Bill: HR 679

Sponsors: Diana Harshbarger, Andy Biggs, Andy Harris, Brian Babin, Clay Higgins, Daniel Webster, Gary J. Palmer, James R. Baird, John R. Moolenaar, Keith Self, Kevin Hern, Mark B. Messmer, Mary E. Miller, Michael Guest, Mike Bost, Randy Feenstra, Randy K. Weber, Rudy Yakym, Sheri Biggs

View United States HR 679 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.